Archive · 31 Jan 2026
Mixed Q3 Results for Indian Firms
Three big Indian companies shared their financial results for the last three months of 2025.
Vedanta did really well, making a lot more money than last year.
Jindal Steel, on the other hand, had a tough time and made much less profit because of higher costs and lower steel prices.
Ambuja Cements also had a hard time, with their profits dropping a lot because of higher costs and lower prices for their products.
These results show that some companies are doing great, while others are facing challenges.
Vedanta reported a 60% year-on-year increase in net profit to ₹7,807 crore, with revenue up 19% to ₹45,899 crore.
Jindal Steel's net profit fell nearly 80% to ₹190 crore due to higher costs and lower steel prices, despite a 10.9% revenue increase to ₹13,026 crore.
Ambuja Cements' net profit dropped 86% to ₹367 crore, though revenue rose 20% to ₹10,181 crore, impacted by higher costs and lower realizations.
Vedanta achieved record EBITDA of ₹15,171 crore, with significant contributions from its zinc and aluminum businesses.
Jindal Steel's EBITDA fell 25% to ₹1,634 crore, and net debt increased to ₹15,443 crore due to ongoing capital expenditure.
- Who
- Vedanta, Jindal Steel, Ambuja Cements
- What
- Reported Q3 financial results
- When
- January 30, 2026
- Where
- India
- Why
- To disclose financial performance for the quarter ended December 2025
- Vedanta Net Profit
- ₹7,807 crore
- Vedanta Revenue
- ₹45,899 crore
- Vedanta EBITDA
- ₹15,171 crore
- Jindal Steel Net Profit
- ₹190 crore
- Jindal Steel Revenue
- ₹13,026 crore
- Jindal Steel EBITDA
- ₹1,634 crore
- Ambuja Cements Net Profit
- ₹367 crore
- Ambuja Cements Revenue
- ₹10,181 crore
- Ambuja Cements EBITDA
- ₹1,353 crore
- Date
- January 30, 2026
Sources
ACME Solar shares surge 6% after strong Q3 show & NHPC power pact
Nalco Q3 profit rises 2% to ₹1,595 cr
Ambuja Cements Q3 net down on higher costs, lower realisation
Vedanta Q3FY26 net profit jumps 60% to Rs 7,807 crore
Jindal Steel Q3 net profit falls almost 80% on higher costs; revenue up 11%
Sun Pharma Q3 earnings: Net profit rises 16% to Rs 3,369 crore; declares Rs 11 dividend
